Topical Tacrolimus (FK506, Protopic) in the Treatment of Atopic Dermatitis. Issue 1 (January 2019)

• Record Type: Journal Article
• Authors: Nagrani, Nicole K.; Zito, Patrick M.
• Is Part Of: Journal of the Dermatology Nurses' Association. Volume 11:Issue 1(2019)
• Publication Date: 2019-01
• Subjects: Atopic Dermatitis -- Calcineurin Inhibitor -- Eczema -- Immunodermatology -- Pediatric Dermatology; Dermatologic nursing -- Periodicals; Skin Diseases -- nursing -- Periodicals; Dermatology -- Periodicals; Dermatologic nursing; Periodicals; 616.505
• DOI: 10.1097/JDN.0000000000000445
• Languages: English
• ISSNs: 1945-760X

Abstract

Abstract : ABSTRACT: Drugs are medications or substances that are used to modify physiologic responses and alleviate associated symptoms. In dermatology, medications and substances are utilized on a daily basis and include topical treatments to anesthetics in micrographic surgery to biologic-acting immunologic agents. The purposes of this section are to focus on drug, specifically how it works and how it is utilized, and to discuss routine alternatives (if available). In this column, we will focus on the uses, mechanism of action, adverse effects, and alternatives to topical tacrolimus (Protopic) in atopic dermatitis.